Sutro Biopharma (STRO) Tax Rate (2022 - 2026)

Sutro Biopharma (STRO) posted Tax Rate of 0.19% for Q4 2025, up 20.2% sequentially from 0.16% in Q2 2025, and up 355.0% YoY from 0.04% in Q4 2024.

Sutro Biopharma (STRO) Tax Rate (2022 - 2026) Analysis & Trends

Sutro Biopharma has reported Tax Rate for 4 years, with the latest figure at 0.19% in Q4 2025.

Quarterly Tax Rate rose 355.0% year-over-year to 0.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.23% (up 685.0% YoY) and the FY2025 annual result came in at 0.05%, up 110.0% from the prior year.
Tax Rate improved to 0.19% in Q4 2025 per STRO's latest filing, from 0.16% in the prior quarter.
Over five years, Tax Rate peaked at 33.74% in Q4 2023 and troughed at 10.63% in Q2 2022.
A 4-year average of 1.67% and a median of 0.39% in 2023 frame the typical range for Tax Rate.
The sharpest annual moves came in 2023 and 2024: Tax Rate jumped 1024 bps in 2023, then sank 3710 bps in 2024.
Over 4 years, Tax Rate stood at 10.63% in 2022, then surged by 417 bps to 33.74% in 2023, then plunged by 110 bps to 3.36% in 2024, then surged by 106 bps to 0.19% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 0.19%, 0.16%, and 3.36% for Q4 2025, Q2 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Sutro Biopharma	339.58 Mn	175.24 Mn	-	0.00%

Download Data